Visual learning formats such as 3D medical animation make complex clinical concepts visible in ways text cannot. Image: Sliced Bread Animation
The role of the pharmacist in the UK is changing faster than at any point in recent memory. Since the launch of NHS Pharmacy First in early 2024, community pharmacies have taken on direct responsibility for assessing and managing common clinical conditions, and from September 2026 every newly registered pharmacist trained under the GPhC’s 2021 education and training standards will qualify as independent prescribers on the day of registration.
This expanding clinical remit demands more than guidelines to read and modules to complete. It demands practice in making realistic decisions in controlled, low-risk environments, where mistakes can be explored without consequences for real patients. Immersive, scenario-based training meets that need directly: by letting pharmacists rehearse realistic consultations, prescribing decisions and difficult patient conversations before they face them in practice, it turns clinical knowledge into confident, applied judgement. The question for pharmacy teams and training providers is no longer whether learning needs to change, but how.
A Clinical Role That Is Expanding Faster Than the Training Behind It
The scale of the shift is easy to underestimate. Pharmacy First, launched across England on 31 January 2024, enables community pharmacists to manage seven defined clinical pathways, including sore throat, earache, infected insect bites, impetigo, shingles, sinusitis and uncomplicated urinary tract infections in women. Where clinically appropriate, pharmacists can supply a restricted range of prescription-only medicines under Patient Group Directions, allowing eligible patients to receive treatment without first obtaining a GP appointment or prescription. More than 95 per cent of community pharmacies in England have registered to deliver the service.
The changes extend well beyond Pharmacy First. Under reforms to initial education and training, pharmacists who complete their MPharm under the GPhC’s 2021 standards are joining the register from summer 2026 as independent prescribers from their first day of practice. For those already registered, the route to prescribing runs through a GPhC-accredited course and supervised learning under a Designated Prescribing Practitioner, as NHS England guidance on becoming an independent prescriber sets out. Together, these reforms redefine what a pharmacist is expected to do: not simply dispense and advise, but assess, decide and prescribe.
Why Applied Learning Matters for Prescribing Decisions
The training infrastructure supporting this expanded role already combines several important elements. There are no mandatory training requirements for Pharmacy First; instead, pharmacy contractors must ensure that pharmacists providing the service are competent and retain evidence of that competence. A self-assessment framework developed by CPPE with NHS England, alongside e-learning resources and opportunities for face-to-face clinical skills development, helps pharmacists identify gaps, refresh knowledge and build the capabilities required for practice. These established approaches form an essential foundation for healthcare education, while immersive and scenario-based learning can provide an additional opportunity to apply that knowledge in realistic situations.
The value of applied learning becomes particularly clear when knowledge has to be translated into clinical judgement. Reading guidance on antimicrobial treatment for uncomplicated urinary tract infections is one thing; sitting across from a patient whose symptoms are ambiguous, weighing red flags against referral criteria and explaining a decision with confidence is another. Guidance, e-learning and clinical skills training provide the necessary knowledge and framework, while repeated application, feedback and reflection can help pharmacists practise using them in situations that more closely resemble real patient encounters.
This is where immersive and scenario-based formats can complement existing training by shifting some of the emphasis from what a learner needs to know to what they need to be able to do: assess a presentation, make a defensible decision, communicate it clearly and recognise the limits of their own competence. For a profession taking on a broader prescribing role, that distinction matters. Applied practice can help turn established knowledge and clinical guidance into confident, consistent decision-making at the point of care.
What Active, Scenario-Based Healthcare Education Looks Like
Active learning in this context takes several practical forms, most of which already exist in other areas of professional training.
Scenario-based e-learning places pharmacists inside branching patient cases that mirror the Pharmacy First pathways. Rather than answering multiple-choice questions about a guideline, the learner works through a consultation: taking a history, identifying red flags, deciding whether to treat under a Patient Group Direction, refer or advise on self-care, and then living with the consequences of that decision as the scenario unfolds.
XR simulation extends this principle into immersive environments, allowing pharmacists to rehearse clinical assessments and consultation flow in a realistic, controlled and low-risk setting. AI avatar role-play adds a further dimension: conversational practice with responsive virtual patients, where the quality of questioning, listening and explanation can be tested and refined without putting a real patient at risk. Visual learning, including 3D medical animation, supports these formats by making mechanisms of action, disease processes and treatment effects visible in ways that text alone cannot achieve.
Specialist studios have emerged to build exactly these kinds of programmes. Sliced Bread, a UK-based studio with more than two decades of experience in regulated industries, is one example of a healthcare education partner developing scenario-based e-learning, XR simulations, AI avatar training and medical animation for pharmaceutical companies, healthcare agencies, providers and medical education organisations. It is one of a growing number of specialist partners now available to a sector that is actively rethinking how clinical capability is built.
Building Confidence in Decision-Making, Prescribing and Patient Communication
What matters most is how these formats connect to the realities of pharmacy practice. Consider the clinical encounters the expanded role now involves. Under Pharmacy First, a pharmacist assessing a patient with earache must take a structured history, examine where appropriate, distinguish between presentations that meet the pathway criteria and those that require onward referral, and then either supply treatment under a Patient Group Direction or explain clearly why a different course of action is needed. Each of these steps is a decision point, and each benefits from having been practised beforehand.
Prescribing practice raises the bar further. Independent prescribers carry responsibility for consultation quality, shared decision-making, safety-netting advice and follow-up arrangements. These are communication-intensive skills as much as clinical ones. Rehearsing difficult conversations, such as explaining to a patient why antibiotics are not appropriate for a viral infection, builds the kind of confidence that passive study rarely produces.
Controlled practice without consequences for real patients is the common thread. When pharmacists can make decisions, make mistakes and receive structured feedback in a simulated environment, they arrive at real consultations better prepared, more confident and safer. For a profession taking on prescribing responsibilities at scale, that preparation is not a luxury; it is a safeguard.
Image by The Yuri Arcurs Collection on Magnific
What Pharmacy Teams and Training Providers Should Consider
For pharmacy owners, superintendents and training leads, the practical question is how to choose learning formats that genuinely match the expanded role. Several criteria stand out. Clinical relevance comes first: scenarios should map directly onto the Pharmacy First pathways and the conditions pharmacists will actually encounter, rather than offering generic clinical content. Scalability matters too, particularly for multiples and locum workforces, where training must reach distributed teams without pulling everyone out of practice for days at a time. Measurability is the third consideration: the value of active learning lies in whether it changes behaviour and decision quality, not in completion rates alone.
The profession's direction of travel is clear. Pharmacists are becoming clinicians who assess, decide and prescribe. The training that supports them will need to be just as active, applied and practice-focused as the role itself.
This article is paid content. It has been reviewed and edited by the Pharmacy Biz editorial team to meet our content standards.
